Proactive Investors - Run By Investors For Investors

Instem's Phil Reason 'very excited' about SEND technology opportunities

Phil Reason, chief executive of the clinical trial software specialist Instem Plc (LON:INS) runs Proactive through the company's 2016 results.

He says he's particularly pleased with the recurring revenue and SaaS software revenue growth.

With regards to their SEND technology, Reason says ''whilst we're excited about the technology opportunity, there's also a great opportunity to offer a technology-enabled outsourced service, where people send us the data ... we put it through our technology platform and we send them back a submission-ready data set''.

Meet Victoria Oil & Gas plc, Avation PLC and Greatland Gold plc at our event, London, 07 September 2017. Register here »
Why Invest In Instem Plc? Read More Here

Register here to be notified of future Instem Plc articles
View full INS profile View Profile

Instem Plc Timeline

Big Picture
September 19 2016

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use